Abstract：
:Although p73alpha induces many of the same cellular events as p53, it is structurally distinct from p53 in that it possesses a unique COOH-terminal domain. To dissect the function of this domain, we performed yeast two-hybrid screening of a HeLa cDNA library using residues 552-636 of p73alpha as bait. Among the clones that showed a specific interaction with p73alpha was AMP-activated protein kinase alpha (AMPKalpha). Additional yeast two-hybrid assays indicated that the betagamma-binding domain of AMPKalpha is critical for the interaction with p73alpha. The interaction was further confirmed in vitro by glutathione S-transferase pull-down, and in vivo by immunoprecipitation and immunofluorescence microscopy. Transient coexpression of AMPKalpha resulted in downregulation of the effect of p73alpha, but not of p53, on various p53-responsive promoters. Chromatin immunoprecipitation indicated p73alpha-dependent recruitment of AMPKalpha to the p21WAF1 promoter. Treatment with 5-aminoimidazole-4-carboxamide ribonucleotide, an agonist of AMPKalpha, and expression of dominant-negative versions of AMPKalpha revealed that the repression of p73alpha was independent of AMPKalpha kinase activity. In addition, cisplatin-induced growth repression was impaired when AMPKalpha was overexpressed. Upon the knock down of AMPKalpha by siRNA, the induction of p21WAF1 by p73alpha was significantly increased. Taken together, these data indicate that AMPKalpha specifically regulates p73alpha by a direct interaction without affecting its phosphorylation status. From these data, we speculate that AMPKalpha may provide a molecular clue to understand the repressive role of the C-terminus of p73alpha in transcription and DNA damage response.
journal_name
Oncogenejournal_title
Oncogeneauthors
Lee YG,Lee SW,Sin HS,Kim EJ,Um SJdoi
10.1038/onc.2008.452subject
Has Abstractpub_date
2009-02-19 00:00:00pages
1040-52issue
7eissn
0950-9232issn
1476-5594pii
onc2008452journal_volume
28pub_type
杂志文章相关文献
ONCOGENE文献大全abstract：:Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acet...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2012.613
更新日期：2014-01-30 00:00:00
abstract：:MyD88 was first characterized as a myeloid differentiation primary response gene in mice, activated in M1 myeloleukemic cells following interleukin-6 (IL-6) induced growth arrest and terminal differentiation. Analysis of expressed sequence tags (ESTs) from activated dendritic cell libraries led to the indentification ...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-12-05 00:00:00
abstract：:Telomerase is a ribonucleoprotein whose activity has been detected in germline cells and in neoplastic and immortal cells. Telomerase compensates the telomere loss arising by the end replication problem by synthesizing telomeric repeats at the 3' end of the eukaryotic chromosomes. Telomerase is reactivated during canc...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201327
更新日期：1997-10-02 00:00:00
abstract：:Many chromosomal regions undergo loss of heterozygosity (LOH) in ovarian adenocarcinomas but few of the target regions have been finely mapped. One of the chromosome arms likely to harbour one or more tumour suppressor genes inactivated in ovarian cancer is the short arm of chromosome 8 which is frequently deleted in ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202028
更新日期：1998-09-03 00:00:00
abstract：:Within the superfamily of ras-related GTP-binding proteins, only ras itself has been shown to act as an oncogene. Seven other proteins, however, have greater than 50% amino acid identity to ras and one of them, rap1A, has been shown to interact with the ras GTPase activating protein, ras-GAP, and to inhibit ras functi...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-03-01 00:00:00
abstract：:DNA damage response (DDR), the guardian of genomic integrity, emerges as an oncogene-inducible biological barrier against progression of cancer beyond its early stages. Recent evidence from both cell culture and animal models as well as analyses of clinical specimens show that activation of numerous oncogenes and loss...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1210881
更新日期：2007-12-10 00:00:00
abstract：:The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2013.546
更新日期：2014-08-21 00:00:00
abstract：:Hypoxic microenvironment supports cancer stem cell survival, causes poor response to anticancer therapy and tumor recurrence. Inhibition of Notch-1 signaling in adenocarcinoma of the lung (ACL) cells causes apoptosis specifically under hypoxia. Here, we found that Akt-1 activation is a key mediator of Notch-1 pro-surv...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.7
更新日期：2010-04-29 00:00:00
abstract：:Induction of apoptosis in tumor cells is an important mechanism of chemotherapy-induced cell death. The tumor-suppressor gene p53 is required for the efficient activation of apoptosis following chemotherapy. However, the molecular mechanism regulating p53-associated apoptosis remains controversial. In this study, we s...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1995-05-18 00:00:00
abstract：:The transcription factor E2F activates genes required for S phase, such as cyclin E and cyclin A. We show that, contrary to long term effects of E2F-1 overexpression, short ectopic overexpression of this transcription factor in logarithmically growing cells does neither affect the cell cycle distribution nor the cell ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201061
更新日期：1997-05-15 00:00:00
abstract：:The Li-Fraumeni Syndrome (LFS) is a rare, dominantly inherited syndrome that features high risk of cancers in childhood and early adulthood. Affected families tend to develop bone and soft tissue sarcomas, breast cancers, brain tumors, leukemias, and adrenocortical carcinomas. In some kindreds, the genetic abnormality...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202783
更新日期：1999-07-08 00:00:00
abstract：:Wild-type p53 protein displays a spectrum of activities including the ability to suppress transformed cell growth to direct apoptotic cell death and to mediate G1 checkpoint in response to cellular DNA damage. Earlier work showed that a self-association defective p53 protein retained transformation suppressor activity...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-08-01 00:00:00
abstract：:Epithelial-to-mesenchymal transition (EMT), marked by the dissolution of cell-cell junctions, loss of cell polarity and increased cell motility, is one of the essential steps for prostate cancer metastasis. However, the underlying mechanism has not been fully explored. We report in this study that Shp2 is upregulated ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2015.184
更新日期：2016-03-10 00:00:00
abstract：:We report the detailed molecular characterization of a human parathyroid adenoma with a clonal parathyroid hormone gene rearrangement. This rearrangement is similar to one we characterized recently in an independent adenoma. In these two, plus a third partially characterized adenoma, one allele of the PTH gene, on 11p...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1991-03-01 00:00:00
abstract：:Using Southern blot analysis of DNA from mouse-hamster somatic cell hybrids, we have mapped Lmyc and Bmyc, two members of the myc family of genes, to mouse chromosomes 4 and 2, respectively. Furthermore, we have compared the regulation of Lmyc and Bmyc expression under different growth conditions and during in vitro d...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1988-12-01 00:00:00
abstract：:To gain better understanding of the molecular alterations responsible for the aggressive growth potential of epidermal growth factor receptor (EGFR)-positive breast cancers, we utilized an expression cloning strategy to seek gene products that mediate the EGF-independent growth of human breast cancer cells. A retrovir...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204537
更新日期：2001-07-05 00:00:00
abstract：:Two alternatively spliced mouse lymphocyte and brain ltk cDNAs predict small transmembrane tyrosine kinases that use CUG translational start codons and that differ upstream of their transmembrane segment. A recently isolated human neuroblastoma ltk cDNA, in contrast, includes a regular AUG start codon and predicts a m...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1993-01-01 00:00:00
abstract：:Ultraviolet (UV) light is a potent mutagenic and genotoxic agent. Whereas DNA damage induced by UV light is known to be responsible for UV-induced genotoxicity, its role in triggering apoptosis is still unclear. We addressed this issue by comparing nucleotide excision repair (NER) deficient 27-1 and 43-3B Chinese hams...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204754
更新日期：2001-09-20 00:00:00
abstract：:A correction to this paper has been published and can be accessed via a link at the top of the paper. ...
journal_title：Oncogene
pub_type： 已发布勘误
doi：10.1038/s41388-019-0835-1
更新日期：2019-07-01 00:00:00
abstract：:Matrix metalloprotease-1 (MMP1) is an important mediator of tumorigenesis, inflammation and tissue remodeling through its ability to degrade critical matrix components. Recent studies indicate that stromal-derived MMP1 may exert direct oncogenic activity by signaling through protease-activated receptor-1 (PAR1) in car...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2013.157
更新日期：2014-04-24 00:00:00
abstract：:Tumor cells typically contain a genome that is highly divergent from the genome of normal, non-transformed cells. This genetic divergence is caused by a number of distinct changes that the tumor cell acquires during its transformation from a normal cell into a tumorigenic counterpart. Changes to the genome include mut...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/onc.2012.576
更新日期：2013-09-19 00:00:00
abstract：:Recently Gadd45, a p53-regulated stress protein, has been implicated in the activation of a G2/M checkpoint after damage by UV radiation and alkylating agents. While inhibitory phosphorylation of Cdc2 and suppression of cyclin B1 levels are known to be involved in G2 delays after genotoxic stress, Gadd45 has now been ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202667
更新日期：1999-05-06 00:00:00
abstract：:The human c-abl oncogene gives rise to different mRNA transcripts which vary primarily in that they possess alternative first exons. In the present study, we present the sequence for the human c-abl 3' untranslated region (3'utr) and show that while human and murine c-abl cDNA sequences are generally homologous, human...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1990-03-01 00:00:00
abstract：:We previously reported that YY-1, a versatile transcription factor, regulates expression of glycophorin gene by binding to its locus control region-like region (Gp-LCR) in combination with E-box binding protein during murine erythroleukemia (MEL) cell differentiation. In the present work, we demonstrated that YY-1 and...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202026
更新日期：1998-08-27 00:00:00
abstract：:Recent explosive advances in next-generation sequencing technology and computational approaches to massive data enable us to analyze a number of cancer genome profiles by whole-genome sequencing (WGS). To explore cancer genomic alterations and their diversity comprehensively, global and local cancer genome-sequencing ...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/onc.2015.90
更新日期：2015-12-03 00:00:00
abstract：:The NF-kappa B precursor p100 (lyt-10, p97, p98) generates after proteolytic processing a 52 kDa subunit, which can bind to kappa B-motifs. A deregulated form of the p100 gene, which is structurally altered by a t(10;14) translocation, has a potential oncogenic role in certain human B cell lymphomas. In this study p10...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1993-08-01 00:00:00
abstract：:The genes for the M2 subunit of ribonucleotide reductase (RRM2), ornithine decarboxylase (ODC1), and 55,000-Daltons protein (P5), are amplified in hydroxyurea-resistant hamster and human cell lines. These genomic sequences have been mapped to hamster chromosome 7 and to human chromosome 2p24-25 near the cytogenetic lo...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1989-09-01 00:00:00
abstract：:DNA double-stranded breaks (DSBs) elicit a checkpoint response that causes a delay in cell cycle progression. Early in the checkpoint response, histone H2AX is phosphorylated in the chromatin region flanking the DSB by ATM/ATR and DNA-PK kinases. The resulting foci of phosphorylated H2AX (gamma-H2AX) serve as a platfo...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2009.501
更新日期：2010-04-15 00:00:00
abstract：:Invasive bladder cancer (BC) is one of the most lethal malignant urological tumors. Although miR-200a has been reported as an onco-miRNA that targets the PTEN gene in endometrioid carcinoma, its biological significance in BC invasion has been poorly explored. In the current study, we found that miR-200a was markedly o...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/s41388-019-1120-z
更新日期：2020-02-01 00:00:00
abstract：:In this study, we investigated the regulation of FOXM1 expression by estrogen receptor alpha (ERalpha) and its role in hormonal therapy and endocrine resistance. FOXM1 protein and mRNA expression was regulated by ER-ligands, including estrogen, tamoxifen (OHT) and fulvestrant (ICI182780; ICI) in breast carcinoma cell ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.47
更新日期：2010-05-20 00:00:00
